Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Shigella: a model of virulence regulation in vivo.

Marteyn B, Gazi A, Sansonetti P.

Gut Microbes. 2012 Mar-Apr;3(2):104-20. doi: 10.4161/gmic.19325. Epub 2012 Mar 1. Review.

PMID:
22356862
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Tips and tricks about Shigella invasion of epithelial cells.

Carayol N, Tran Van Nhieu G.

Curr Opin Microbiol. 2013 Feb;16(1):32-7. doi: 10.1016/j.mib.2012.11.010. Epub 2013 Jan 11. Review.

PMID:
23318141
[PubMed - indexed for MEDLINE]
3.

[Pathogenesis of Shigella: the study of bacteria-host interplay at the intestinal mucosal barriers].

Sasakawa C.

Nihon Saikingaku Zasshi. 2012;67(4):257-68. Review. Japanese.

PMID:
23269180
[PubMed - indexed for MEDLINE]
Free Article
4.

Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival?

Phalipon A, Sansonetti PJ.

Immunol Cell Biol. 2007 Feb-Mar;85(2):119-29. Epub 2007 Jan 9. Review.

PMID:
17213832
[PubMed - indexed for MEDLINE]
5.

Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion.

Schroeder GN, Hilbi H.

Clin Microbiol Rev. 2008 Jan;21(1):134-56. doi: 10.1128/CMR.00032-07. Review.

PMID:
18202440
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

ShiA abrogates the innate T-cell response to Shigella flexneri infection.

Ingersoll MA, Zychlinsky A.

Infect Immun. 2006 Apr;74(4):2317-27.

PMID:
16552062
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

In vivo versus in vitro protein abundance analysis of Shigella dysenteriae type 1 reveals changes in the expression of proteins involved in virulence, stress and energy metabolism.

Kuntumalla S, Zhang Q, Braisted JC, Fleischmann RD, Peterson SN, Donohue-Rolfe A, Tzipori S, Pieper R.

BMC Microbiol. 2011 Jun 24;11:147. doi: 10.1186/1471-2180-11-147.

PMID:
21702961
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Shigella type III secretion effectors: how, where, when, for what purposes?

Parsot C.

Curr Opin Microbiol. 2009 Feb;12(1):110-6. doi: 10.1016/j.mib.2008.12.002. Epub 2009 Jan 20. Review.

PMID:
19157960
[PubMed - indexed for MEDLINE]
9.

Shigella spp. and enteroinvasive Escherichia coli pathogenicity factors.

Parsot C.

FEMS Microbiol Lett. 2005 Nov 1;252(1):11-8. Epub 2005 Sep 15. Review.

PMID:
16182469
[PubMed - indexed for MEDLINE]
10.

Shigella infection of intestinal epithelium and circumvention of the host innate defense system.

Ashida H, Ogawa M, Mimuro H, Sasakawa C.

Curr Top Microbiol Immunol. 2009;337:231-55. doi: 10.1007/978-3-642-01846-6_8. Review.

PMID:
19812985
[PubMed - indexed for MEDLINE]
11.

Analysis of virulence plasmid gene expression defines three classes of effectors in the type III secretion system of Shigella flexneri.

Le Gall T, Mavris M, Martino MC, Bernardini ML, Denamur E, Parsot C.

Microbiology. 2005 Mar;151(Pt 3):951-62.

PMID:
15758240
[PubMed - indexed for MEDLINE]
Free Article
12.

Shigella deliver an effector protein to trigger host microtubule destabilization, which promotes Rac1 activity and efficient bacterial internalization.

Yoshida S, Katayama E, Kuwae A, Mimuro H, Suzuki T, Sasakawa C.

EMBO J. 2002 Jun 17;21(12):2923-35.

PMID:
12065406
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Delivery of dangerous goods: type III secretion in enteric pathogens.

Zaharik ML, Gruenheid S, Perrin AJ, Finlay BB.

Int J Med Microbiol. 2002 Mar;291(8):593-603. Review.

PMID:
12008913
[PubMed - indexed for MEDLINE]
14.

IcsB, secreted via the type III secretion system, is chaperoned by IpgA and required at the post-invasion stage of Shigella pathogenicity.

Ogawa M, Suzuki T, Tatsuno I, Abe H, Sasakawa C.

Mol Microbiol. 2003 May;48(4):913-31.

PMID:
12753186
[PubMed - indexed for MEDLINE]
15.

The Shigella virulence gene regulatory cascade: a paradigm of bacterial gene control mechanisms.

Dorman CJ, Porter ME.

Mol Microbiol. 1998 Aug;29(3):677-84. Review.

PMID:
9723908
[PubMed - indexed for MEDLINE]
16.

Shigella effector IpaB-induced cholesterol relocation disrupts the Golgi complex and recycling network to inhibit host cell secretion.

Mounier J, Boncompain G, Senerovic L, Lagache T, Chr├ętien F, Perez F, Kolbe M, Olivo-Marin JC, Sansonetti PJ, Sauvonnet N.

Cell Host Microbe. 2012 Sep 13;12(3):381-9. doi: 10.1016/j.chom.2012.07.010.

PMID:
22980334
[PubMed - indexed for MEDLINE]
Free Article
17.

The inside story of Shigella invasion of intestinal epithelial cells.

Carayol N, Tran Van Nhieu G.

Cold Spring Harb Perspect Med. 2013 Oct 1;3(10):a016717. doi: 10.1101/cshperspect.a016717. Review.

PMID:
24086068
[PubMed - indexed for MEDLINE]
18.

MxiE regulates intracellular expression of factors secreted by the Shigella flexneri 2a type III secretion system.

Kane CD, Schuch R, Day WA Jr, Maurelli AT.

J Bacteriol. 2002 Aug;184(16):4409-19.

PMID:
12142411
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Meta-analytic approach to the accurate prediction of secreted virulence effectors in gram-negative bacteria.

Sato Y, Takaya A, Yamamoto T.

BMC Bioinformatics. 2011 Nov 14;12:442. doi: 10.1186/1471-2105-12-442.

PMID:
22078363
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence.

Zurawski DV, Mitsuhata C, Mumy KL, McCormick BA, Maurelli AT.

Infect Immun. 2006 Oct;74(10):5964-76.

PMID:
16988276
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk